# ClinicalTrials.gov record NCT06264609

> PeptideScanner retained ClinicalTrials.gov record NCT06264609 at 2026-07-30T16:20:49.326Z. Its registry update date was 2026-04-01, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct06264609-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06264609-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06264609-teriparatide-v1.json
- Content SHA-256: `fd4775fb295f8d13ee4e0698284128fd12c34f3f79e9c8b143292a5753153258`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06264609 ([`ctg-observation-nct06264609-2026-04-01-9c49ecd11946`](#source-ctg-observation-nct06264609-2026-04-01-9c49ecd11946))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06264609 at 2026-07-30T16:20:49.326Z. Its registry update date was 2026-04-01, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct06264609-2026-04-01-9c49ecd11946`](#source-ctg-observation-nct06264609-2026-04-01-9c49ecd11946))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06264609 at 2026-07-30T16:20:49.326Z. Its registry update date was 2026-04-01, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct06264609-2026-04-01-9c49ecd11946`](#source-ctg-observation-nct06264609-2026-04-01-9c49ecd11946))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06264609-2026-04-01-9c49ecd11946`](#source-ctg-observation-nct06264609-2026-04-01-9c49ecd11946))

## Sources

<a id="source-ctg-observation-nct06264609-2026-04-01-9c49ecd11946"></a>
- **ClinicalTrials.gov record NCT06264609 · retained source version 2026-04-01:9c49ecd119464b11d6166167784dcac1fd3d41df87fdfc71e8c2028664c260d7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06264609) (`ctg-observation-nct06264609-2026-04-01-9c49ecd11946`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06264609." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06264609-teriparatide-v1.json SHA-256: fd4775fb295f8d13ee4e0698284128fd12c34f3f79e9c8b143292a5753153258.